Prognosis and antibody profiles in survivors of critical illness from COVID-19: a prospective multicentre cohort study.

Br J Anaesth · 2022 · PMC8616737 · PMID 34980470

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

There was also persistent immunity against SARS-CoV-2 as measured by high titres of antibodies to SARS-CoV-2 (although on a decreasing trend) and active virus-specific immune cell function.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.